Retrieve FDA Calendar

{
  "data": [
    {
      "catalyst": "PDUFA Date",
      "description": "The FDA extended the new target action date for a decision under the Prescription Drug User Fee Act (PDUFA) to February 24, 2024, but agreed to work with Iovance to expedite the remaining review for a potentially earlier approval date.",
      "drug": "Lifileucel",
      "end_date": "2024-02-24",
      "indication": "for the Treatment of Advanced Melanoma",
      "start_date": "2024-02-24",
      "status": "NDA",
      "ticker": "IOVA"
    }
  ]
}